METIS Innovative is a physician-founded investment firm focused on early-stage medical devices and technologies in the neurosciences. Established in 2017, it combines clinical insights from neurosurgeons with financial analysis to identify high-potential opportunities.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
METIS Innovative is a physician-founded investment firm established in 2017, dedicated to improving the lives of individuals suffering from neurologic illnesses through advancements in neurotechnology. Founded by two prominent neurosurgeons and a veteran in capital accrual, METIS aims to identify and invest in early-stage medical devices and technologies within the neurosciences sector. The firm focuses on leveraging clinical insights from practicing neurosurgeons to evaluate the potential success of targeted technologies, ensuring that investments align with the needs of patients and healthcare providers.
METIS Innovative invests in early-stage companies developing medical devices and technologies aimed at treating neurologic conditions. Their investment strategy combines clinical insights from practicing neurosurgeons with financial analysis to identify high-potential opportunities in the neurotechnology space.
METIS Innovative leverages clinical insights from practicing neurosurgeons to provide unique value to portfolio companies, ensuring that investments are not only financially sound but also clinically viable. Their expertise in the neurosciences sector helps startups navigate the complexities of medical device development and market entry.
METIS Innovative focuses on early-stage companies developing medical devices and technologies for neurologic conditions. They look for startups that combine clinical insights with innovative solutions in neurotechnology.
Founders can reach out through the contact form on their website. A well-prepared pitch deck that outlines the technology, market potential, and team background is essential.
The unique combination of clinical expertise from practicing neurosurgeons and financial analysis sets METIS apart. This dual perspective allows them to identify high-potential opportunities in the neurotechnology sector effectively.
While specific geographic preferences are not detailed, METIS focuses on companies that are innovating in the neurotechnology space, which may include both domestic and international startups.
METIS Innovative invests across various stages, including pre-seed, seed, seed-plus, and Series A, but specific check sizes are not disclosed.
METIS Innovative offers strategic insights and resources to their portfolio companies, leveraging their clinical and financial expertise to enhance growth and innovation.
Organizations that do similar work to METIS Innovative.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorAccelerating life sciences innovation in Massachusetts.
InvestorTransforming healthcare through strategic investments.
InvestorCamford Capital is an early-stage venture capital firm based in Menlo Park, California, focusing on investments across technology and healthcare sectors. The firm leverages a diverse team to support its portfolio companies.
Superscout Pro
Is this page right?Reviewed · How the research works